Inflammatory Markers

A recent review of electronic health records showed that 4% of adults who were hospitalized with COVID-19 in the beginning of the pandemic were newly diagnosed with diabetes.

At 10 years, higher baseline levels of systemic inflammatory markers, including plasma interleukin-6 and fibrinogen, were associated with greater cognitive decline for adults with type 2 diabetes, according to data.